Introduction:
Edge Pharmacy Services invests US$ 1.5 Million to expand its manufacturing capabilities to include an additional 20, 000 square feet of space.
Features:
Edge is known manufacturing a wide variety of compounded pharmaceuticals with specific focuses in operating room anesthesia, medications for ophthalmic surgery, ENT, dermatology, and allergy treatment.
The company plans for the long term solution and it invests over $1.5 million into expanding production capacity. In addition, new capabilities implemented during the expansion will enhance production capacity by 5 times when compared to its current capacity.
With the expansion of its manufacturing facility, Edge plans to keep pace with the production demands.
It is very typical for Edge not only to bring hospitals and surgery centres into compliance with these new regulations, but also save them hundreds of thousands of dollars per year in pharmaceutical costs.
Edge has been diligent in complying with new rules and regulations implemented by the Boards of Pharmacy, the Food and Drug Administration, USP-795, and USP-797.
Edge's 2017 facility expansion is the latest effort and commitment to continue those standards.
Specifications:
| Name | Edge Pharmacy Services |
| Location | Colchester, VT, USA |
| Type | Expansion |
| Estimated Cost | US$ 1.5 million |
| Parties Involved | Edge Pharmacy Services |
